Definitely not wesso
I'm always open
I cant make the company hold the vaccine div as you are aware so I'll cop what comes
I'd be happy to derisk spinning out the HSV but I'd prefer to keep HPV
HPV is where I think we have a better chance of success
Interesting this collaboration though
It's almost like they've made it up on their own
Maybe it is to be used to obtain funding?
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-179
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.11 |
Change
0.110(0.61%) |
Mkt cap ! $348.1M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.11 | $17.81 | $18.36K | 1.019K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13 | $18.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.14 | 565 | 2 |
View Market Depth
| Last trade - 12.01pm 08/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |